Tenecteplase Before Interhospital Transfer in Acute Basilar Artery Occlusion at 4.5 to 24 Hours

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 316 participants.

Also called NCT07203625

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 316 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07203625
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07203625. Randomized; single masking; primary purpose treatment. Start 2026-01-20 (actual); primary completion 2027-12-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Tenecteplase Before Interhospital Transfer in Acute Basilar Artery Occlusion at 4.5 to 24 Hours
Acronym
OPTION-2
Condition
Acute Ischemic Stroke
Condition
Basilar Artery Occlusion
Intervention (Drug)
Tenecteplase thrombolysis
Lead sponsor
Xuanwu Hospital, Beijing (class: other)

Record details

Record id
cardio:ct-nct07203625
Content hash
54dbf9593e902c5c3325647178145b53bc91739315a8d8fd8ac882b4587e6619